Tilray Brands (TLRY) Stock Price, News & Analysis

Company Overview

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products. The company has expanded into adjacent consumer categories via strategic acquisitions, integrating brands in hemp foods, craft beverages and pet wellness. This diversified approach supports Tilray Brands’ goal of serving both medical and adult-use markets while extending its reach into broader lifestyle and health-and-wellness segments.

Founded in 2013, Tilray became the first global cannabis company to list on a major U.S. exchange in 2018. In 2021, it completed a transformative merger with Aphria, creating one of the world’s largest cannabis companies by production capacity. Headquartered in New York with integrated operations in Canada, the United States, Europe, Australia, Latin America and the Caribbean, Tilray Brands leverages international scale to access regulated markets and support global research collaborations.

Tilray Brands is led by a management team with deep experience in consumer packaged goods, pharmaceuticals and regulated industries. The company’s executive leadership emphasizes product innovation, regulatory compliance and operational excellence, positioning Tilray Brands to pursue growth opportunities across its core cannabis business and complementary consumer lifestyle categories.

Key Stats

• Today's Range: $1.93 to $2.32
• 50-Day Range: $0.57 to $1.85
• 52-Week Range: $0.35 to $2.32
• Volume: 298.01 million shs
• Average Volume: 48.36 million shs
• Market Capitalization: $2.31 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.94
• Consensus Rating: Hold

Tilray Brands Stock Analysis - MarketRank™

Tilray Brands scored higher than 26% of companies evaluated by MarketBeat, and ranked 678th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Hold

Consensus Rating

Tilray Brands has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 2 buy ratings, 4 hold ratings, and 1 sell rating.

Downside Risk

Tilray Brands has a consensus price target of $1.94, representing about 6.0% downside from its current price of $2.06.

Amount of Analyst Coverage

Tilray Brands has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Tilray Brands are expected to grow in the coming year, from ($0.20) to ($0.10) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Tilray Brands is -0.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tilray Brands is -0.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Tilray Brands has a P/B Ratio of 1.47. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

14.04% of the outstanding shares of Tilray Brands have been sold short.

Short Interest Ratio / Days to Cover

Tilray Brands has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tilray Brands has recently decreased by 4.58%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tilray Brands does not currently pay a dividend.

Dividend Growth

Tilray Brands does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

14.04% of the outstanding shares of Tilray Brands have been sold short.

Short Interest Ratio / Days to Cover

Tilray Brands has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tilray Brands has recently decreased by 4.58%, indicating that investor sentiment is improving.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.65

News Sentiment

Tilray Brands has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 25 news articles for Tilray Brands this week, compared to 14 articles on an average week.

Search Interest

102 people have searched for TLRY on MarketBeat in the last 30 days. This is an increase of 23% compared to the previous 30 days.

MarketBeat Follows

102 people have added Tilray Brands to their MarketBeat watchlist in the last 30 days. This is an increase of 132% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Tilray Brands insiders have bought more of their company's stock than they have sold. Specifically, they have bought $120,750.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 0.84% of the stock of Tilray Brands is held by insiders.

Percentage Held by Institutions

Only 9.35% of the stock of Tilray Brands is held by institutions.

TLRY Stock Analysis - Frequently Asked Questions

How have TLRY shares performed this year?

Tilray Brands' stock was trading at $1.33 on January 1st, 2025. Since then, TLRY shares have increased by 55.0% and is now trading at $2.0620.

How were Tilray Brands' earnings last quarter?

Tilray Brands, Inc. (NASDAQ:TLRY) issued its quarterly earnings data on Monday, July, 28th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.05. The company had revenue of $224.54 million for the quarter, compared to analysts' expectations of $250.41 million. Tilray Brands had a negative trailing twelve-month return on equity of 6.83% and a negative net margin of 265.69%.
Read the conference call transcript.

When did Tilray Brands IPO?

Tilray Brands (TLRY) raised $135 million in an IPO on Thursday, July 19th 2018. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. Cowen and Company acted as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

How do I buy shares of Tilray Brands?

Shares of TLRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tilray Brands own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tilray Brands investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), Humana (HUM), Marinus Pharmaceuticals (MRNS), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 7/28/2025
• Today: 10/09/2025
• Next Earnings (Estimated): 10/09/2025
• Fiscal Year End: 5/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:TLRY
• Previous Symbol: NASDAQ:TLRY
• CIK: 1731348
• Web: www.tilray.com
• Phone: 206-432-9325
• Fax: N/A
• Employees: 2,842
• Year Founded: 2013

Price Target and Rating

• Average Price Target for Tilray Brands: $1.94
• High Price Target: $3.00
• Low Price Target: $1.00
• Potential Upside/Downside: -2.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.14
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.31)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.19 billion
• Net Margins: -265.69%
• Pretax Margin: -280.33%
• Return on Equity: -6.83%
• Return on Assets: -5.45%

Debt

• Debt-to-Equity Ratio: 0.20
• Current Ratio: 2.46
• Quick Ratio: 1.49

Sales & Book Value

• Annual Sales: $821.31 million
• Price / Sales: 2.67
• Cash Flow: $0.17 per share
• Price / Cash Flow: 11.83
• Book Value: $1.40 per share
• Price / Book: 1.42

Miscellaneous

• Outstanding Shares: 1,100,530,000
• Free Float: 1,091,286,000
• Market Cap: $2.19 billion
• Optionable: Optionable
• Beta: 1.98